Kevin Kotler’s Broadfin Capital Joins HealthCor in Idera

Broadfin Capital, Idera Pharmaceuticals: Just now, Kevin Kotler’s Broadfin Capital disclosed adding Idera Pharmaceuticals Inc (NASDAQ:IDRA) to its equity portfolio in a filing with the Securities and Exchange Commission. The fund, with an inclination towards healthcare stocks, reported purchasing over 4.5 million shares of Idera, which gives Kotler an almost 7.7% position in the company. At the current price of Idera Pharmaceuticals’ stock, the value of the position acquired by Broadfin amounts to some $13.2 million. HealthCor Management reported a 5.6% stake earlier this morning.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Disclosure: none